PharmaPlanter Technologies offers high-precision gene editing solutions to support functional genomics, disease modeling, and therapeutic development. Our proprietary CRISPR-based platform enables efficient gene knockouts and fluorescent tag knock-ins for accurate, reproducible genome modifications. With optimized guide RNA design, donor templates, and advanced delivery methods, we help researchers achieve clean, validated edits for confident biological insights.

Our platform enables:

• Complete gene disruption (KO) via targeted double-strand breaks and indel formation,

• Seamless knock-in of fluorescent reporters (e.g., EGFP, mCherry) at endogenous loci for real-time visualization of protein dynamics,

• High editing efficiency with minimal off-target effects, achieved through optimized guide RNA design, delivery systems, and repair template engineering.

Precise genetic modification is an essential capability in modern biomedical research, enabling scientists to systematically interrogate gene function, model disease mechanisms, and engineer next-generation therapeutics. Advances in gene editing—particularly CRISPR-Cas technologies—have unlocked new possibilities in functional genomics, drug discovery, and synthetic biology by enabling accurate, efficient, and scalable genome engineering. However, achieving consistent and clean genetic edits, such as complete gene knockouts or precise insertion of functional tags, still requires specialized expertise, optimized workflows, and rigorous validation to ensure experimental success and biological relevance.

At PharmaPlanter Technologies, we have developed a proprietary gene editing platform designed to deliver high-precision genome modifications with exceptional efficiency and specificity. Our platform supports both gene knockouts, for functional gene disruption studies, and fluorescent tag knock-ins, allowing real-time tracking of endogenous protein expression, localization, and dynamics. By integrating advanced CRISPR-Cas systems with optimized guide RNA design, donor template strategies, and high-performance delivery technologies, we ensure seamless editing outcomes tailored to a wide range of biological applications. This enables researchers to build reliable, reproducible models that accelerate discovery and inform therapeutic development.